Qilian International Holding Group (BGM) Free Cash Flow (2018 - 2024)
Qilian International Holding Group (BGM) free cash flow from Sep 30, 2018 to Sep 30, 2024. The TTM Qilian International Holding Group (BGM) free cash flow is $300K. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Qilian International Holding Group (BGM) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +130.77% |
| All Time | -33.01% |
Annual Free Cash Flow change of Qilian International Holding Group (BGM)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2024 | $300K | +130.77% |
| 2023 | $130K | -98.62% |
| 2022 | $9.42M | -400.00% |
| 2021 | -$3.14M | -167.82% |
| 2020 | $4.63M | -485.83% |
| 2019 | -$1.20M | -136.14% |
| 2018 | $3.32M | N/A |
Comparison Qilian International Holding Group (BGM) five years free cash flow CAGR with competitors
Qilian International Holding Group (BGM) five years free cash flow CAGR is -50.87%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| LNTH | Lantheus Holdings Inc | 89.22% | -275.41% |
| ORGO | Organogenesis Holdings Inc - Class A | 87.05% | -271.13% |
| PRFX | PRF Technologies Ltd | 60.45% | -218.84% |
| HROW | Harrow Inc | 51.26% | -200.78% |
| SBFM | Sunshine Biopharma Inc | 46.84% | -192.08% |
| ANIP | ANI Pharmaceuticals Inc | 45.89% | -190.21% |
| ALKS | Alkermes plc | 36.06% | -170.90% |
| PCRX | Pacira BioSciences Inc | 27.91% | -154.87% |
| ALVO | Alvotech | 26.48% | -152.06% |
| NBIX | Neurocrine Biosciences Inc | 25.83% | -150.79% |
| AMPH | Amphastar Pharmaceuticals Inc | 24.53% | -148.22% |
| COLL | Collegium Pharmaceutical Inc | 23.23% | -145.68% |
| CRDL | Cardiol Therapeutics Inc - Class A | 20.58% | -140.45% |
| UTHR | United Therapeutics Corp | 12.12% | -123.82% |
| PAHC | Phibro Animal Health Corp - Class A | 6.13% | -112.05% |
| ZTS | Zoetis Inc - Class A | 4.90% | -109.62% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -105.75% |
| HCM | HUTCHMED (China) Ltd | 2.39% | -104.71% |
| INM | InMed Pharmaceuticals Inc | 1.61% | -103.16% |
| EOLS | Evolus Inc | 0.82% | -101.62% |
| BHC | Bausch Health Companies Inc | 0.61% | -101.21% |